These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29677199)

  • 1. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
    Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
    Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
    Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
    Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
    Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
    Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine and G6PD: a primer for clinicians.
    Chu CS; Freedman DO
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
    Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
    Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rajapakse S; Rodrigo C; Fernando SD
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness Analysis of Sex-Stratified
    Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
    Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
    Abla N; Marrast AC; Jambert E; Richardson N; Duparc S; Almond L; Rowland Yeo K; Pan X; Tarning J; Zhao P; Culpepper J; Waitt C; Koldeweij C; Cole S; Butler AS; Khier S; Möhrle JJ; El Gaaloul M
    Malar J; 2024 Sep; 23(1):287. PubMed ID: 39334094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vivax malaria in pregnancy and lactation: a long way to health equity.
    Brummaier T; Gilder ME; Gornsawun G; Chu CS; Bancone G; Pimanpanarak M; Chotivanich K; Nosten F; McGready R
    Malar J; 2020 Jan; 19(1):40. PubMed ID: 31969155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study).
    Santos A; Brito M; Silva E; Rocha F; Oliveira A; Dávila R; Gama H; Albuquerque J; Paiva M; Baía-Silva D; Sampaio V; Balieiro P; Rufatto R; Grewal Daumerie P; Peterka C; Edilson Lima F; Monteiro W; Arcanjo A; Silva R; Batista Pereira D; Lacerda M; Murta F
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012197. PubMed ID: 38837977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linked-evidence modelling of qualitative G6PD testing to inform low- and intermediate-dose primaquine treatment for radical cure of Plasmodium vivax.
    Gatton ML
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012486. PubMed ID: 39236082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.